Immunological ignorance of silent antigens as an explanation of tumor evasion (Q41701856)

7 October 2017

1 reference

title

Immunological ignorance of silent antigens as an explanation of tumor evasion (English)

1 reference

7 October 2017

1 reference

Chen L

1

1 reference

7 October 2017

1 January 1998

1 reference

7 October 2017

1 reference

7 October 2017

19

1 reference

7 October 2017

1

1 reference

7 October 2017

27-30

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 October 2017

1 reference

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Direct analysis of tumor-associated peptide antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Dominance and crypticity of T cell antigenic determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

A role for CD95 ligand in preventing graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Peripheral T cell tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Immunology taught by viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

The development of new immunotherapies for the treatment of cancer using interleukin-2. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Costimulation of T cells for tumor immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Serial triggering of many T-cell receptors by a few peptide-MHC complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

T cell activation determined by T cell receptor number and tunable thresholds.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

T cell responses are governed by avidity and co-stimulatory thresholds

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Biology of graft-vs.-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

CTLA-4 ligation blocks CD28-dependent T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Major histocompatibility complex class I allele‐specific peptide libraries: Identification of peptides that mimic an H‐Y T cell epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901180-8

7 January 2021

10.1016/S0167-5699(97)01180-8

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

9465485